Beauty Health Co (NASDAQ:SKIN) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET
Company Participants
Eduardo Rodriguez - Senior Director, M&A and IR
Andrew Stanleick - President, CEO & Director
Liyuan Woo - CFO
Conference Call Participants
Bruce Jackson - The Benchmark Company
Jonathan Block - Stifel, Nicolaus & Company
Olivia Tong - Raymond James & Associates
Linda Bolton-Weiser - D.A. Davidson & Co.
Korinne Wolfmeyer - Piper Sandler & Co.
Allen Gong - JPMorgan Chase & Co.
Kyle Rose - Canaccord Genuity
Navann Ty - BNP Paribas Exane
Margaret Kaczor - William Blair & Company
Operator
Good morning, and welcome to The Beauty Health Company's Fourth Quarter and Fiscal Year 2022 Earnings Conference Call. [Operator Instructions].
I would now like to turn the conference over to Eduardo Rodriguez, Senior Director of M&A and Investor Relations. Please go ahead.
Eduardo Rodriguez
Thank you, operator, and good morning, everyone. Thank you for joining The Beauty Health Company's conference call to discuss the company's fourth quarter and full year 2022 financial results, which were released this morning and can be found on our website at beautyhealth.com. Also available on our website is an investor presentation that will be referenced during this call.
With me on the call today are Beauty Health's President and Chief Executive Officer, Andrew Stanleick; and Chief Financial Officer, Liyuan Woo.
Before we get started, I would like to remind you of the company's safe harbor language. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. For a further discussion of risks related to our business, see our filings with the SEC.
This call will present non-GAAP financial measures such as adjusted gross margin and adjusted EBITDA. Reconciliation of these non-GAAP measures to the most comparable GAAP measures are included in the earnings release furnished to the SEC and available on our website.
I will now turn the call over to Andrew.
Andrew Stanleick
Thank you, Eduardo. Good morning, everyone, and thank you for joining Beauty Health's Fourth Quarter and Full Year 2022 Earnings Call. To begin, I will discuss our performance and accomplishments for the year, my first serving as CEO of this incredible category-creating company. I am extremely proud of the progress of our team in these past 12 months, and I am pleased to share the results with you today. I will also discuss our outlook for 2023 before Liyuan provides more detail on the numbers. We will then be happy to take your questions.